Suzhou Highfine Biotech Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: CNE1000064T6
CNY
58.85
-0.03 (-0.05%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
599.68
450.93
388.38
445.40
367.40
280.50
191.25
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
599.68
450.93
388.38
445.40
367.40
280.50
191.25
Raw Material Cost
405.91
277.96
244.27
256.85
199.99
151.68
103.63
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
85.47
59.77
47.54
36.73
27.23
64.85
12.80
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.86
0.24
0.18
0.39
0.22
0.14
0.07
Selling and Distribution Expenses
44.76
42.49
33.90
22.76
24.57
48.62
15.80
Other Expenses
-5.27
-2.90
-2.20
-1.61
-1.33
-4.29
-0.58
Total Expenditure (Excl Depreciation)
484.33
351.48
303.90
300.65
238.75
222.37
126.47
Operating Profit (PBDIT) excl Other Income
115.39999999999999
99.39999999999999
84.5
144.70000000000002
128.7
58.099999999999994
64.80000000000001
Other Income
18.17
55.69
34.62
7.01
1.91
-2.43
4.56
Operating Profit (PBDIT)
161.16
169.31
126.81
161.42
136.27
56.91
69.99
Interest
0.86
0.24
0.18
0.39
0.22
0.14
0.07
Exceptional Items
7.24
5.64
0.22
-0.29
-0.08
-0.10
-0.33
Gross Profit (PBDT)
193.77
172.97
144.12
188.54
167.41
128.82
87.62
Depreciation
38.26
20.07
14.37
11.78
6.92
2.05
2.07
Profit Before Tax
129.27
154.64
112.49
148.96
129.05
54.62
67.52
Tax
18.43
20.58
13.51
19.59
17.65
14.22
9.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
114.65
134.05
98.97
129.37
111.40
40.40
58.12
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
114.65
134.05
98.97
129.37
111.40
40.40
58.12
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.81
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
110.84
134.05
98.97
129.37
111.40
40.40
58.12
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,352.85
2,268.27
2,211.86
482.28
372.57
260.83
173.41
Earnings per share (EPS)
1.07
1.24
0.92
1.2
1.03
0.37
0.54
Diluted Earnings per share
1.07
1.24
0.92
1.2
1.03
0.37
0.54
Operating Profit Margin (Excl OI)
17.46%
20.75%
20.04%
32.02%
34.69%
20.43%
33.13%
Gross Profit Margin
27.94%
38.74%
32.66%
36.09%
37.01%
20.2%
36.39%
PAT Margin
19.12%
29.73%
25.48%
29.05%
30.32%
14.4%
30.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 33.00% vs 16.09% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -17.38% vs 35.45% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 25.88% vs 23.21% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 350.00% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Suzhou Highfine Biotech Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
599.68
0
599.68
Other Operating Income
0.00
0.00
0.00
Total Operating income
599.68
0
599.68
Raw Material Cost
405.91
0
405.91
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
85.47
0
85.47
Power Cost
0
0
0.00
Manufacturing Expenses
0.86
0
0.86
Selling and Distribution Expenses
44.76
0
44.76
Other Expenses
-5.27
0.00
-5.27
Total Expenditure (Excl Depreciation)
484.33
0
484.33
Operating Profit (PBDIT) excl Other Income
115.35
0.00
115.35
Other Income
18.17
0
18.17
Operating Profit (PBDIT)
161.16
0
161.16
Interest
0.86
0
0.86
Exceptional Items
7.24
0
7.24
Gross Profit (PBDT)
193.77
0
193.77
Depreciation
38.26
0
38.26
Profit Before Tax
129.27
0
129.27
Tax
18.43
0
18.43
Provisions and contingencies
0
0
0.00
Profit After Tax
114.65
0
114.65
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
114.65
0
114.65
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.81
0
-3.81
Other related items
0.00
0.00
0.00
Consolidated Net Profit
110.84
0
110.84
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,352.85
0
2,352.85
Earnings per share (EPS)
1.07
0
1.07
Diluted Earnings per share
1.07
0
1.07
Operating Profit Margin (Excl OI)
17.46%
0%
0.00
17.46%
Gross Profit Margin
27.94%
0%
0.00
27.94%
PAT Margin
19.12%
0%
0.00
19.12%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 59.97 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 33.00% vs 16.09% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 11.08 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -17.38% vs 35.45% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.30 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 25.88% vs 23.21% in Dec 2024

Annual - Interest
Interest 0.09 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 350.00% vs 0.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.46%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024